We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NantHealth Inc | NASDAQ:NH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.35 | 1.39 | 0 | 01:00:00 |
Move Reinforces NantHealth’s Commitment to Improved Connectivity For Payers, Providers, and Revenue Cycle Organizations
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interfaces (APIs) that will offer provider and revenue cycle organizations connectivity to payers via the NaviNet Open Platform. This update enables faster information retrieval and easier payer access through a secure real-time, HIPAA-compliant gateway to payers. The workflows include Eligibility & Benefits, Claim Status Inquiry, Authorizations, and Referrals. NaviNet also offers APIs for payers to access the secure and flexible NaviNet Open Document Exchange platform.
The NaviNet Open Platform APIs provide benefits to stakeholders across the healthcare industry.
“NantHealth is delighted to bring this additional functionality to our network of health plans and providers, leading to enhanced interoperability with automation, security, ease of use and scalability,” said Chris House, Senior Vice President, Product Engineering at NantHealth. “NaviNet has been a leader in payer-provider engagement for 20 years, creating value through innovation and enabling healthcare to successfully operate more efficiently, resulting in better care for patients and members.”
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies, provides leading solutions across the continuum of care for physicians, payors, patients and biopharmaceutical organizations. NantHealth enables the use of cutting-edge data and technology toward the goals of empowering clinical decision support and improving patient outcomes. NantHealth’s comprehensive product portfolio combines the latest technology in payor/provider platforms that exchange information in near-real time (NaviNet and Eviti), and molecular profiling services that combine comprehensive DNA & RNA tumor-normal profiling with pharmacogenomics analysis (GPS Cancer®). For more information, please visit www.nanthealth.com or follow us on Twitter, Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005201/en/
MEDIA CONTACT NantHealth Jen Hodson Jen@nant.com 562-397-3639
1 Year NantHealth Chart |
1 Month NantHealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions